The increasing prevalence of metabolic & chronic disorders and malnutrition drives the demand for parenteral nutrition solutions across the globe, thus stimulating the demand for parenteral nutrition bags.
For instance, the State of Food Security and Nutrition in the World 2023 report revealed that approximately 2.4 billion individuals lacked consistent access to nutritious food in 2022, with child malnutrition rates remaining alarmingly high.
Metabolic disorders such as diabetes, hyperlipidemia, and malnutrition often require specialized clinical nutrition support, which can be provided through parenteral nutrition bags.
These bags offer a convenient and efficient way to deliver essential nutrients and medications to patients who cannot consume food orally or through enteral feeding, making them a crucial component in managing these conditions.
Thus, as the prevalence of metabolic disorders, malnutrition, and other chronic diseases continues to rise globally, the demand for parenteral nutrition bags is expected to increase, thereby fueling market growth.
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
The global parenteral nutrition bags market was valued at USD 749.6 million in 2023 and is expected to reach USD 1.3 billion by end of 2032, driven by the increasing prevalence of chronic diseases such as cancer, GI disorders, and malnutrition.
The single-chamber bags segment in the market reached USD 400.4 million in 2023, due to the convenience, ease of use, and compatibility with various formulations.
Asia Pacific parenteral nutrition bags market held 31.7% revenue share in 2023 and is expected to reach USD 436.4 million by 2032, attributed to the region's large and aging population, coupled with increasing incidences of chronic diseases and a growing awareness of the importance of nutrition.
AdvaCare Pharma, Baxter International Inc., B. Braun Medical Inc., Diffuplast S.r.l., Grifols SA, GVS S.p.A., HEMEDIS GmbH, INFRA S.r.l., Technoflex and Valmed s.r.l